Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tempus AI, Inc. (TEM)
USD57.83
+1.90 (+3.40%)
US NASDAQ Healthcare Medical - Healthcare Information Services
Address
600 West Chicago Avenue 60654
Chicago, IL, US
Chicago, IL, US
CEO
Eric Lefkofsky
Website
tempus.com
IPO
2024-06-14
CIK 1717115 ISIN US88023B1035
Description
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
News Sentiment (7d)
3 articles
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD57.83
+1.90 (+3.40%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7M
Beta
3.62
Float Shares
105.25M
Free Float %
60.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.12% | -11.93% | +9.34% | -7.54% | -33.97% | -20.49% | -25.11% | +16.65% | +16.65% | +16.65% | +16.65% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (13 ratings, all time)
Buy
Price Targets & DCF
Current price
57.83
Low
59.00
+2.0%
Consensus
75.43
+30.4%
Median
80.00
+38.3%
High
100.00
+72.9%
Ratings Trend (MoM)
59% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 8 | 0 |
| Hold | 6 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
72.00
+24.5%
|
| Last Quarter | 6 |
76.33
+32.0%
|
| Last Year | 16 |
84.56
+46.2%
|
| All Time | 27 |
72.30
+25.0%
|
Quality scores
Altman Z-Score
3.60
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+83.4% ★ Q1'26: +36.1% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+69.4% ★ Q1'26: -77.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-33.3% Q1'26: -23.4% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-17.8% Q1'26: -22.2% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-41.0% Q1'26: -52.2% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+7.5% Q1'26: +5.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-3.67× Q1'26: -3.98× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 12 Rev. Ana. 8 EPS Ana. |
Dec 2027 12 Rev. Ana. 9 EPS Ana. |
Dec 2028 9 Rev. Ana. 6 EPS Ana. |
Dec 2029 4 Rev. Ana. 4 EPS Ana. |
Dec 2030 4 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
531.82M
est: 562.02M (-5.4%)
|
693.40M
est: 696.27M (-0.4%)
|
1.27B
est: 1.27B (+0.4%)
|
1.59B
1.55B – 1.60B
+25.6% YoY
|
1.94B
1.88B – 1.98B
+21.7% YoY
|
2.30B
2.30B – 2.31B
+19.0% YoY
|
2.69B
2.62B – 2.73B
+16.5% YoY
|
3.12B
3.05B – 3.17B
+16.3% YoY
|
| EBITDA |
-133.33M
est: -325.50M (+59.0%)
|
-610.42M
est: -403.25M (-51.4%)
|
-222.36M
est: -733.90M (+69.7%)
|
-921.95M
-927.75M – -900.58M
-25.6% YoY
|
-1.12B
-1.14B – -1.09B
-21.7% YoY
|
-1.33B
-1.34B – -1.33B
-19.0% YoY
|
-1.56B
-1.58B – -1.52B
-16.5% YoY
|
-1.81B
-1.84B – -1.77B
-16.3% YoY
|
| EBIT |
-166.66M
est: -360.01M (+53.7%)
|
-647.66M
est: -446.01M (-45.2%)
|
-226.45M
est: -811.72M (+72.1%)
|
-1.02B
-1.03B – -996.07M
-25.6% YoY
|
-1.24B
-1.27B – -1.20B
-21.7% YoY
|
-1.48B
-1.48B – -1.47B
-19.0% YoY
|
-1.72B
-1.75B – -1.68B
-16.5% YoY
|
-2.00B
-2.03B – -1.95B
-16.3% YoY
|
| Net Income |
-214.12M
est: -813.84M (+73.7%)
|
-705.81M
est: -320.83M (-120.0%)
|
-245.03M
est: -103.58M (-136.6%)
|
-69.37M
-109.98M – -28.76M
+33.0% YoY
|
-9.22M
-131.35M – 112.91M
+86.7% YoY
|
78.65M
-14.42M – 171.72M
+953.3% YoY
|
304.09M
294.93M – 310.14M
+286.6% YoY
|
487.94M
473.24M – 497.65M
+60.5% YoY
|
| SGA |
296.76M
est: 418.40M (-29.1%)
|
755.35M
est: 518.34M (+45.7%)
|
731.74M
est: 943.35M (-22.4%)
|
1.19B
1.16B – 1.19B
+25.6% YoY
|
1.44B
1.40B – 1.47B
+21.7% YoY
|
1.72B
1.71B – 1.72B
+19.0% YoY
|
2.00B
1.95B – 2.03B
+16.5% YoY
|
2.32B
2.27B – 2.36B
+16.3% YoY
|
| EPS |
-1.73
est: -4.63 (+62.6%)
|
-4.60
est: -1.76 (-161.4%)
|
-1.41
est: -0.60 (-135.2%)
|
-0.37
-0.63 – -0.17
+38.5% YoY
|
-0.09
-0.75 – 0.65
+74.9% YoY
|
0.43
-0.08 – 0.99
+563.2% YoY
|
1.75
1.69 – 1.78
+307.0% YoY
|
2.80
2.72 – 2.86
+60.5% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-08 | BTIG | Buy | Buy | Maintain |
| 2026-05-06 | TD Cowen | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-286.24M
OE per share TTM
-1.63
Owner's Yield
-3.41%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
14.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
136
Total invested
320.43M
Insider transactions (90d)
1
Beneficial owners (>5%)
6
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eric Paul Lefkofsky | 54.42M | 34.30% | 5.96M | 48.46M | 5.96M | 48.46M | IN | United States | 2024-11-12 | ↗ |
| 2 | Blue Media, LLC | 31.59M | 20.60% | — | 31.59M | — | 31.59M | OO | Delaware | 2024-11-12 | ↗ |
| 3 | BK TL21 LLC | 16.56M | 11.10% | — | 16.56M | — | 16.56M | CO | Delaware | 2024-08-08 | ↗ |
| 4 | Keywell | 16.56M | 11.10% | 16.56M | — | — | 16.56M | IN | Delaware | 2024-08-08 | ↗ |
| 5 | Gray Media, LLC | 9.61M | 6.40% | — | 9.61M | — | 9.61M | OO | Delaware | 2024-11-12 | ↗ |
| 6 | Tempus Labs, Inc. | 9.22M | 15.80% | 9.22M | — | 9.22M | — | CO | Delaware | 2023-12-05 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
136
-375 vs prev Q
New positions
26
Closed positions
350
Increased
74
Reduced
35
Put/Call ratio
359.80
Calls held
500.00
Puts held
179.9K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 10.26M +817.0K (+8.7%) | 605.77M -156.3M (-20.5%) | 5.86% +0.418 pp | 0.01% -0.003 pp | USD56.96 +3.7% | 7 qtrs — |
| 2 | BAILLIE GIFFORD & CO | 8.74M -951.0K (-9.8%) | 516.18M -266.1M (-34.0%) | 5.00% -0.594 pp | 0.43% -0.151 pp | USD63.54 -7.1% | 3 qtrs — |
| 3 | ARK INVESTMENT MANAGEMENT LLC | 7.56M +381.8K (+5.3%) | 446.28M -132.9M (-22.9%) | 4.32% +0.181 pp | 2.96% -0.486 pp | USD44.01 +34.2% | 7 qtrs — |
| 4 | BLACKROCK, INC. | 7.52M +778.8K (+11.6%) | 443.83M -99.9M (-18.4%) | 4.30% +0.411 pp | 0.01% -0.002 pp | USD66.86 -11.7% | 5 qtrs — |
| 5 | CATALYTIC WEALTH RIA, LLC | 6.76M +6.8M (+100.0%) | 399.27M +399.3M (+100.0%) | 3.86% +3.865 pp | 14.66% +14.663 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 6 | SOFTBANK GROUP CORP. | 5.41M +— (+0.0%) | 319.19M -117.1M (-26.8%) | 3.09% -0.028 pp | 2.06% +0.384 pp | USD33.34 +77.1% | 7 qtrs — |
| 7 | JPMORGAN CHASE & CO | 4.91M -19.4K (-0.4%) | 289.93M -107.9M (-27.1%) | 2.81% -0.037 pp | 0.02% -0.006 pp | USD51.53 +14.6% | 7 qtrs — |
| 8 | JANE STREET GROUP, LLC | 3.79M -892.6K (-19.1%) | 223.96M -154.2M (-40.8%) | 2.17% -0.534 pp | 0.03% -0.024 pp | USD55.62 +6.2% | 6 qtrs — |
| 9 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.50M +41.7K (+1.2%) | 206.96M -72.5M (-25.9%) | 2.00% +0.006 pp | 2.39% -0.316 pp | USD42.42 +39.2% | 7 qtrs — |
| 10 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.50M +41.7K (+1.2%) | 206.96M -72.5M (-26.0%) | 2.00% +0.006 pp | 0.12% -0.039 pp | USD43.55 +35.6% | 7 qtrs — |
| 11 | MORGAN STANLEY | 2.08M -332.8K (-13.8%) | 123.02M -72.0M (-36.9%) | 1.19% -0.203 pp | 0.01% -0.005 pp | USD56.82 +3.9% | 7 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.87M +141.7K (+8.2%) | 110.48M -29.1M (-20.8%) | 1.07% +0.072 pp | 0.01% -0.002 pp | USD71.06 -16.9% | 7 qtrs — |
| 13 | FRANKLIN RESOURCES INC | 1.86M +405.7K (+27.9%) | 109.94M -7.6M (-6.5%) | 1.06% +0.224 pp | 0.03% -0.002 pp | USD39.36 +50.0% | 7 qtrs — |
| 14 | STATE STREET CORP | 1.62M +143.7K (+9.8%) | 95.44M -23.4M (-19.7%) | 0.92% +0.075 pp | 0.00% -0.001 pp | USD69.65 -15.2% | 3 qtrs — |
| 15 | TWO SIGMA INVESTMENTS, LP | 1.59M +357.2K (+28.9%) | 93.98M -5.6M (-5.7%) | 0.91% +0.198 pp | 0.13% -0.016 pp | USD62.99 -6.3% | 3 qtrs — |
| 16 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.57M -33.6K (-2.1%) | 92.92M -36.8M (-28.4%) | 0.90% -0.028 pp | 0.33% -0.109 pp | USD74.64 -20.9% | 5 qtrs — |
| 17 | ALPHABET INC. | 1.55M +— (+0.0%) | 91.59M -33.6M (-26.8%) | 0.89% -0.008 pp | 3.55% -1.647 pp | USD33.34 +77.1% | 7 qtrs — |
| 18 | UBS GROUP AG | 1.48M -701.8K (-32.1%) | 87.62M -88.8M (-50.3%) | 0.85% -0.412 pp | 0.01% -0.013 pp | USD57.49 +2.7% | 6 qtrs — |
| 19 | EXOR CAPITAL LLP | 1.14M +359.7K (+45.9%) | 67.53M +4.3M (+6.7%) | 0.65% +0.202 pp | 1.18% +0.008 pp | USD41.43 +42.5% | 7 qtrs — |
| 20 | BANK OF AMERICA CORP /DE/ | 1.14M -1.3M (-52.6%) | 67.35M -127.0M (-65.4%) | 0.65% -0.737 pp | 0.00% -0.008 pp | USD65.09 -9.3% | 7 qtrs — |
| 21 | D. E. SHAW & CO., INC. | 972.2K -1.5M (-60.9%) | 57.41M -143.4M (-71.4%) | 0.56% -0.879 pp | 0.03% -0.082 pp | USD70.13 -15.8% | 4 qtrs — |
| 22 | PEAK6 LLC | 968.8K +584.3K (+152.0%) | 57.21M +26.2M (+84.3%) | 0.55% +0.332 pp | 0.11% +0.061 pp | USD64.09 -7.9% | 5 qtrs — |
| 23 | TORONTO DOMINION BANK | 900.0K +— (+0.0%) | 54.35M -18.3M (-25.2%) | 0.51% -0.005 pp | 0.08% -0.032 pp | USD80.71 -26.8% | 2 qtrs — |
| 24 | CITADEL ADVISORS LLC | 902.6K +885.0K (+5,044.3%) | 53.30M +51.9M (+3,663.7%) | 0.52% +0.506 pp | 0.01% +0.008 pp | USD58.56 +0.8% | 7 qtrs — |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 856.7K +473.6K (+123.7%) | 50.59M +19.7M (+63.6%) | 0.49% +0.269 pp | 0.01% +0.002 pp | USD53.36 +10.7% | 7 qtrs — |
| 26 | NORGES BANK | 816.8K +816.8K (+100.0%) | 48.23M +48.2M (+100.0%) | 0.47% +0.467 pp | 0.01% +0.005 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 743.3K +33.6K (+4.7%) | 43.89M -13.4M (-23.4%) | 0.42% +0.016 pp | 0.01% -0.002 pp | USD79.17 -25.4% | 3 qtrs — |
| 28 | MARSHALL WACE, LLP | 738.6K +677.6K (+1,109.1%) | 43.62M +38.7M (+784.6%) | 0.42% +0.387 pp | 0.04% +0.035 pp | USD60.59 -2.5% | 7 qtrs — |
| 29 | GOLDMAN SACHS GROUP INC | 726.5K +500.7K (+221.8%) | 42.90M +24.7M (+135.5%) | 0.42% +0.285 pp | 0.01% +0.003 pp | USD58.61 +0.8% | 6 qtrs — |
| 30 | CLEAR STREET GROUP INC. | 723.4K +7.0K (+1.0%) | 42.71M -15.1M (-26.1%) | 0.41% +0.000 pp | 0.16% -0.039 pp | USD80.50 -26.6% | 2 qtrs — |
| 31 | MAREX GROUP PLC | 679.8K -79.9K (-10.5%) | 40.14M -21.2M (-34.5%) | 0.39% -0.050 pp | 0.25% -0.181 pp | USD71.24 -17.1% | 3 qtrs — |
| 32 | GILDER GAGNON HOWE & CO LLC | 576.8K -201.3K (-25.9%) | 34.06M -28.7M (-45.8%) | 0.33% -0.119 pp | 0.36% -0.280 pp | USD70.74 -16.5% | 5 qtrs — |
| 33 | UBS ASSET MANAGEMENT AMERICAS INC | 571.8K +336.5K (+143.0%) | 33.76M +14.8M (+77.8%) | 0.33% +0.191 pp | 0.01% +0.003 pp | USD60.86 -3.0% | 4 qtrs — |
| 34 | LEGAL & GENERAL GROUP PLC | 558.3K +70.0K (+14.3%) | 32.97M -6.4M (-16.3%) | 0.32% +0.038 pp | 0.01% -0.002 pp | USD55.13 +7.1% | 7 qtrs — |
| 35 | FIRST TRUST ADVISORS LP | 521.0K -69.1K (-11.7%) | 30.77M -16.9M (-35.4%) | 0.30% -0.043 pp | 0.02% -0.013 pp | USD74.80 -21.1% | 6 qtrs — |
| 36 | TREXQUANT INVESTMENT LP | 507.9K +180.4K (+55.1%) | 29.99M +3.6M (+13.5%) | 0.29% +0.101 pp | 0.27% -0.005 pp | USD73.02 -19.1% | 2 qtrs — |
| 37 | WALLEYE TRADING LLC | 484.0K +12.7K (+2.7%) | 28.58M -9.5M (-24.9%) | 0.28% +0.005 pp | 0.04% -0.017 pp | USD61.58 -4.1% | 6 qtrs — |
| 38 | NORTHERN TRUST CORP | 479.3K +14.3K (+3.1%) | 28.30M -9.2M (-24.6%) | 0.27% +0.006 pp | 0.00% -0.001 pp | USD72.44 -18.5% | 4 qtrs — |
| 39 | MILLENNIUM MANAGEMENT LLC | 471.3K +357.9K (+315.7%) | 27.83M +18.7M (+204.1%) | 0.27% +0.204 pp | 0.01% +0.008 pp | USD62.86 -6.1% | 7 qtrs — |
| 40 | QUBE RESEARCH & TECHNOLOGIES LTD | 465.5K +465.5K (+100.0%) | 27.49M +27.5M (+100.0%) | 0.27% +0.266 pp | 0.03% +0.028 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 41 | WELLINGTON MANAGEMENT GROUP LLP | 432.7K +432.7K (+100.0%) | 25.55M +25.6M (+100.0%) | 0.25% +0.247 pp | 0.00% +0.005 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 42 | CAPITAL FUND MANAGEMENT S.A. | 386.6K +178.2K (+85.5%) | 22.83M +6.0M (+35.7%) | 0.22% +0.101 pp | 0.06% +0.019 pp | USD65.64 -10.0% | 4 qtrs — |
| 43 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 384.5K -4.6K (-1.2%) | 22.70M -8.7M (-27.7%) | 0.22% -0.005 pp | 0.01% -0.002 pp | USD40.72 +45.0% | 7 qtrs — |
| 44 | PATIENT CAPITAL MANAGEMENT, LLC | 382.1K -5.7K (-1.5%) | 22.56M -8.7M (-27.9%) | 0.22% -0.005 pp | 0.87% -0.382 pp | USD63.54 -7.1% | 3 qtrs — |
| 45 | SG AMERICAS SECURITIES, LLC | 372.0K +335.0K (+903.7%) | 21.97M +19.0M (+634.3%) | 0.21% +0.191 pp | 0.03% +0.018 pp | USD58.69 +0.6% | 5 qtrs — |
| 46 | INVESCO LTD. | 371.7K +65.8K (+21.5%) | 21.95M -2.7M (-11.1%) | 0.21% +0.036 pp | 0.00% -0.001 pp | USD66.81 -11.6% | 4 qtrs — |
| 47 | KADENSA CAPITAL LTD | 364.9K +76.9K (+26.7%) | 21.55M -1.7M (-7.3%) | 0.21% +0.043 pp | 2.24% -0.156 pp | USD50.52 +16.9% | 4 qtrs — |
| 48 | BAMCO INC /NY/ | 355.4K +92.2K (+35.0%) | 20.99M -257.8K (-1.2%) | 0.20% +0.051 pp | 0.06% +0.001 pp | USD52.36 +12.8% | 7 qtrs — |
| 49 | CAPTION MANAGEMENT, LLC | 355.0K +— (+0.0%) | 20.96M -7.7M (-26.8%) | 0.20% -0.002 pp | 0.14% -0.080 pp | USD78.06 -24.4% | 5 qtrs — |
| 50 | WELLS FARGO & COMPANY/MN | 313.4K +63.0K (+25.1%) | 18.51M -1.7M (-8.4%) | 0.18% +0.035 pp | 0.00% -0.001 pp | USD69.88 -15.5% | 7 qtrs — |
| 51 | TWO SIGMA ADVISERS, LP | 311.4K -1.5K (-0.5%) | 18.39M -6.9M (-27.2%) | 0.18% -0.003 pp | 0.04% -0.015 pp | USD63.54 -7.1% | 5 qtrs — |
| 52 | TUDOR INVESTMENT CORP ET AL | 310.9K +246.3K (+381.7%) | 18.36M +13.1M (+252.4%) | 0.18% +0.141 pp | 0.03% +0.025 pp | USD63.55 -7.1% | 2 qtrs — |
| 53 | BANK OF NEW YORK MELLON CORP | 300.6K +737.0 (+0.2%) | 17.75M -6.5M (-26.7%) | 0.17% -0.001 pp | 0.00% -0.002 pp | USD61.96 -4.7% | 5 qtrs — |
| 54 | CASDIN CAPITAL, LLC | 294.1K +— (+0.0%) | 17.37M -6.4M (-26.8%) | 0.17% -0.002 pp | 1.08% -0.901 pp | USD80.71 -26.8% | 2 qtrs — |
| 55 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 264.3K +73.5K (+38.5%) | 15.61M +207.5K (+1.3%) | 0.15% +0.041 pp | 1.08% +0.033 pp | USD63.40 -6.9% | 6 qtrs — |
| 56 | ABRDN PLC | 263.0K +102.9K (+64.2%) | 15.53M +2.6M (+20.2%) | 0.15% +0.058 pp | 0.02% +0.004 pp | USD49.61 +19.0% | 5 qtrs — |
| 57 | NUVEEN, LLC | 248.2K +14.9K (+6.4%) | 14.66M -4.2M (-22.2%) | 0.14% +0.007 pp | 0.00% -0.001 pp | USD70.42 -16.1% | 3 qtrs — |
| 58 | LPL FINANCIAL LLC | 241.5K +12.2K (+5.3%) | 14.26M -4.2M (-22.9%) | 0.14% +0.006 pp | 0.00% -0.002 pp | USD61.95 -4.7% | 6 qtrs — |
| 59 | PRICE T ROWE ASSOCIATES INC /MD/ | 217.9K -397.8K (-64.6%) | 12.87M -36.8M (-74.1%) | 0.12% -0.231 pp | 0.00% -0.004 pp | USD79.11 -25.4% | 7 qtrs — |
| 60 | WOLVERINE ASSET MANAGEMENT LLC | 210.2K +— (+0.0%) | 12.41M -4.6M (-26.8%) | 0.12% -0.001 pp | 0.10% -0.028 pp | USD80.71 -26.8% | 2 qtrs — |
| 61 | RTW INVESTMENTS, LP | 200.0K +— (+0.0%) | 11.81M -4.3M (-26.8%) | 0.11% -0.001 pp | 0.12% -0.081 pp | USD48.24 +22.4% | 7 qtrs — |
| 62 | CWM, LLC | 194.2K +2.0K (+1.0%) | 11.47M -4.0M (-26.1%) | 0.11% +0.000 pp | 0.03% -0.016 pp | USD45.64 +29.4% | 5 qtrs — |
| 63 | SWISS NATIONAL BANK | 182.9K +3.7K (+2.1%) | 10.80M -3.7M (-25.3%) | 0.10% +0.001 pp | 0.01% -0.002 pp | USD66.72 -11.5% | 3 qtrs — |
| 64 | BNP PARIBAS ARBITRAGE, SNC | 173.1K -1.1M (-86.4%) | 10.22M -92.6M (-90.1%) | 0.10% -0.636 pp | 0.00% -0.050 pp | USD76.40 -22.7% | 5 qtrs — |
| 65 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 172.9K +172.9K (+100.0%) | 10.21M +10.2M (+100.0%) | 0.10% +0.099 pp | 0.02% +0.017 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 66 | WALLEYE CAPITAL LLC | 170.7K +113.6K (+199.0%) | 10.08M +5.5M (+118.7%) | 0.10% +0.065 pp | 0.03% +0.014 pp | USD66.29 -10.9% | 4 qtrs — |
| 67 | CAPTRUST FINANCIAL ADVISORS | 169.0K +34.0K (+25.2%) | 9.98M -919.4K (-8.4%) | 0.10% +0.019 pp | 0.02% -0.003 pp | USD60.36 -2.2% | 6 qtrs — |
| 68 | SQUAREPOINT OPS LLC | 166.8K -89.9K (-35.0%) | 9.85M -10.9M (-52.5%) | 0.10% -0.053 pp | 0.01% -0.010 pp | USD69.54 -15.1% | 4 qtrs — |
| 69 | DIMENSIONAL FUND ADVISORS LP | 165.9K +134.1K (+422.6%) | 9.80M +7.2M (+282.6%) | 0.09% +0.077 pp | 0.00% +0.002 pp | USD59.30 -0.4% | 4 qtrs — |
| 70 | ARES MANAGEMENT LLC | 164.4K +— (+0.0%) | 9.71M -3.6M (-26.8%) | 0.09% -0.001 pp | 0.55% -0.048 pp | USD47.88 +23.3% | 7 qtrs — |
| 71 | VESTMARK ADVISORY SOLUTIONS, INC. | 158.1K -2.4K (-1.5%) | 9.34M -3.6M (-28.0%) | 0.09% -0.002 pp | 0.13% -0.121 pp | USD54.07 +9.2% | 6 qtrs — |
| 72 | JUMP FINANCIAL, LLC | 149.5K -167.2K (-52.8%) | 8.83M -16.7M (-65.5%) | 0.09% -0.097 pp | 0.11% -0.197 pp | USD80.71 -26.8% | 4 qtrs — |
| 73 | GROUP ONE TRADING, L.P. | 148.0K -160.9K (-52.1%) | 8.74M -16.2M (-65.0%) | 0.08% -0.094 pp | 0.02% -0.029 pp | USD80.71 -26.8% | 2 qtrs — |
| 74 | BARCLAYS PLC | 145.7K +144.8K (+15,638.9%) | 8.61M +8.6M (+16,320.0%) | 0.08% +0.083 pp | 0.00% +0.002 pp | USD58.98 +0.1% | 7 qtrs — |
| 75 | POINT72 ASSET MANAGEMENT, L.P. | 136.4K +136.4K (+100.0%) | 8.05M +8.1M (+100.0%) | 0.08% +0.078 pp | 0.01% +0.009 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 76 | CONTRARIUS GROUP HOLDINGS LTD | 135.0K +135.0K (+100.0%) | 7.97M +8.0M (+100.0%) | 0.08% +0.077 pp | 0.39% +0.387 pp | USD59.05 +0.0% | 1 qtrs NEW |
| 77 | WS MANAGEMENT LLLP | 130.0K -240.0K (-64.9%) | 7.68M -22.2M (-74.3%) | 0.07% -0.139 pp | 0.63% -2.621 pp | USD71.89 -17.9% | 3 qtrs — |
| 78 | TWIN TREE MANAGEMENT, LP | 123.4K +34.9K (+39.4%) | 7.29M +143.9K (+2.0%) | 0.07% +0.020 pp | 0.06% +0.034 pp | USD70.77 -16.6% | 3 qtrs — |
| 79 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 121.5K -10.6K (-8.0%) | 7.18M -3.5M (-32.7%) | 0.07% -0.007 pp | 0.05% -0.027 pp | USD35.45 +66.6% | 7 qtrs — |
| 80 | KOHLBERG KRAVIS ROBERTS & CO. L.P. | 117.7K +— (+0.0%) | 6.95M -2.5M (-26.8%) | 0.07% -0.001 pp | 0.11% -0.048 pp | USD80.71 -26.8% | 2 qtrs — |
| 81 | RAYMOND JAMES FINANCIAL INC | 117.4K -42.5K (-26.6%) | 6.93M -6.0M (-46.3%) | 0.07% -0.025 pp | 0.00% -0.002 pp | USD42.90 +37.6% | 5 qtrs — |
| 82 | VOLEON CAPITAL MANAGEMENT LP | 111.5K +2.2K (+2.0%) | 6.58M -2.2M (-25.4%) | 0.06% +0.001 pp | 0.14% -0.074 pp | USD80.29 -26.5% | 2 qtrs — |
| 83 | H&H INTERNATIONAL INVESTMENT, LLC | 110.0K +110.0K (+100.0%) | 6.50M +6.5M (+100.0%) | 0.06% +0.063 pp | 0.04% +0.037 pp | USD59.05 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
4
Shares acquired
—
Shares disposed
166.3K
Cash buys
—
Cash sales
4.00
Net activity
-166,250
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 105,430 | 51.03 | 5.38M | 15,684,039 | I | ↗ |
| 2026-03-26 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 7,784 | 47.42 | 369.1K | 15,789,469 | I | ↗ |
| 2026-03-02 | Rogers James William | Officer | S-Sale | D | Class A Common Stock | 11,414 | 50.69 | 578.6K | 127,248 | D | ↗ |
| 2026-03-02 | Epstein David R | Director | S-Sale | D | Class A Common Stock | 250 | 50.69 | 12.7K | 25,801 | D | ↗ |
| 2026-02-20 | Schoenherr Thomas Edward | Officer | — | — | Class A Common Stock | 0 | 0.00 | — | 94,967 | D | ↗ |
| 2026-02-20 | Rogers James William | Officer | A-Award | A | Class A Common Stock | 37,496 | 0.00 | — | 138,662 | D | ↗ |
| 2026-02-20 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 10,849 | 60.30 | 654.2K | 127,018 | D | ↗ |
| 2026-02-20 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | A-Award | A | Class A Common Stock | 263,430 | 0.00 | — | 2,253,056 | D | ↗ |
| 2026-02-20 | Fukushima Ryan | Officer | A-Award | A | Class A Common Stock | 74,993 | 0.00 | — | 769,347 | D | ↗ |
| 2026-02-20 | Bartolucci Ryan M | Officer | A-Award | A | Class A Common Stock | 12,998 | 0.00 | — | 54,157 | D | ↗ |
| 2026-02-19 | Rogers James William | Officer | S-Sale | D | Class A Common Stock | 10,084 | 59.05 | 595.5K | 101,166 | D | ↗ |
| 2026-02-19 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 8,143 | 59.05 | 480.8K | 99,447 | D | ↗ |
| 2026-02-19 | Phelps Erik | Officer | S-Sale | D | Class A Common Stock | 5,650 | 59.05 | 333.6K | 79,816 | D | ↗ |
| 2026-02-19 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 923 | 59.70 | 55.1K | 8,908,283 | I | ↗ |
| 2026-02-19 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 9,592 | 59.05 | 566.4K | 694,354 | D | ↗ |
| 2026-02-19 | Bartolucci Ryan M | Officer | S-Sale | D | Class A Common Stock | 2,902 | 59.05 | 171.4K | 41,159 | D | ↗ |
| 2026-02-02 | Epstein David R | Director | S-Sale | D | Class A Common Stock | 370 | 59.41 | 22.0K | 26,051 | D | ↗ |
| 2026-01-28 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 30,526 | 66.06 | 2.02M | 16,055,469 | I | ↗ |
| 2026-01-05 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 5,000 | 64.26 | 321.3K | 148,808 | I | ↗ |
| 2026-01-02 | Doudna Jennifer A | Director | S-Sale | D | Class A Common Stock | 1,250 | 60.17 | 75.2K | 22,702 | D | ↗ |
| 2025-12-18 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 11,207 | 66.04 | 740.1K | 16,188,469 | I | ↗ |
| 2025-12-16 | Phelps Erik | Officer | S-Sale | D | Class A Common Stock | 1,302 | 67.42 | 87.8K | 89,280 | D | ↗ |
| 2025-12-11 | Rogers James William | Officer | S-Sale | D | Class A Common Stock | 4,209 | 72.09 | 303.4K | 127,007 | D | ↗ |
| 2025-12-05 | Frederick Wayne A.I. | Director | S-Sale | D | Class A Common Stock | 3,675 | 77.23 | 283.8K | 24,836 | D | ↗ |
| 2025-12-01 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 2,128 | 75.59 | 160.9K | 155,776 | I | ↗ |
| 2025-12-01 | Epstein David R | Director | S-Sale | D | Class A Comnmon Stock | 250 | 75.55 | 18.9K | 26,421 | D | ↗ |
| 2025-12-01 | Doudna Jennifer A | Director | S-Sale | D | Class A Common Stock | 676 | 75.55 | 51.1K | 23,952 | D | ↗ |
| 2025-11-25 | Fukushima Ryan | Officer | G-Gift | D | Class A Common Stock | 125,135 | 0.00 | — | 703,946 | D | ↗ |
| 2025-11-24 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 12,874 | 75.00 | 965.6K | 107,590 | D | ↗ |
| 2025-11-24 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 133,000 | 74.10 | 9.86M | 16,571,469 | I | ↗ |
| 2025-11-20 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 6,221 | 65.59 | 408.0K | 9,068,312 | I | ↗ |
| 2025-11-19 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 200 | 69.41 | 13.9K | 120,464 | D | ↗ |
| 2025-11-18 | Rogers James William | Officer | S-Sale | D | Class A Common Stock | 2,269 | 66.15 | 150.1K | 131,216 | D | ↗ |
| 2025-11-18 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 1,627 | 66.15 | 107.6K | 126,851 | D | ↗ |
| 2025-11-18 | Phelps Erik | Officer | S-Sale | D | Class A Common Stock | 2,428 | 65.26 | 158.5K | 91,687 | D | ↗ |
| 2025-11-18 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 5,262 | 66.15 | 348.1K | 2,003,213 | D | ↗ |
| 2025-11-18 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 6,942 | 65.26 | 453.0K | 832,238 | D | ↗ |
| 2025-11-18 | Bartolucci Ryan M | Officer | S-Sale | D | Class A Common Stock | 1,261 | 65.26 | 82.3K | 44,634 | D | ↗ |
| 2025-11-11 | Doudna Jennifer A | Director | S-Sale | D | Class A Comnmon Stock | 1,926 | 71.45 | 137.6K | 24,628 | D | ↗ |
| 2025-11-03 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 2,300 | 88.84 | 204.3K | 127,200 | I | ↗ |
| 2025-11-03 | Epstein David R | Director | S-Sale | D | Class A Common Stock | 370 | 90.00 | 33.3K | 26,671 | D | ↗ |
| 2025-10-28 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 3,903 | 91.55 | 357.3K | 17,337,470 | I | ↗ |
| 2025-10-06 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 715 | 90.84 | 65.0K | 134,285 | I | ↗ |
| 2025-09-25 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 16,049 | 75.09 | 1.21M | 9,191,484 | I | ↗ |
| 2025-09-02 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 300 | 72.73 | 21.8K | 144,700 | I | ↗ |
| 2025-09-02 | Epstein David R | Director | S-Sale | D | Class A Comnmon Stock | 250 | 73.64 | 18.4K | 27,041 | D | ↗ |
| 2025-08-27 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 6,278 | 72.89 | 457.6K | 9,267,755 | I | ↗ |
| 2025-08-26 | Leonsis Theodore | Director | S-Sale | D | Class A Common Stock | 20,000 | 75.83 | 1.52M | 66,756 | I | ↗ |
| 2025-08-19 | Rogers James William | Officer | S-Sale | D | Class A Common Stock | 7,345 | 74.63 | 548.2K | 138,656 | D | ↗ |
| 2025-08-19 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 132 | 75.61 | 10.0K | 132,056 | D | ↗ |
| 2025-08-19 | Phelps Erik | Officer | S-Sale | D | Class A Common Stock | 89 | 75.61 | 6.7K | 94,115 | D | ↗ |
| 2025-08-19 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 425 | 75.61 | 32.1K | 2,020,042 | D | ↗ |
| 2025-08-19 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 17,035 | 74.63 | 1.27M | 839,605 | D | ↗ |
| 2025-08-19 | Bartolucci Ryan M | Officer | S-Sale | D | Class A Common Stock | 46 | 75.61 | 3.5K | 45,895 | D | ↗ |
| 2025-08-13 | Leonsis Theodore | Director | S-Sale | D | Class A Common Stock | 44,000 | 69.90 | 3.08M | 86,756 | I | ↗ |
| 2025-08-01 | Epstein David R | Director | S-Sale | D | Class A Comnmon Stock | 370 | 55.16 | 20.4K | 27,291 | D | ↗ |
| 2025-07-28 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 5,735 | 65.23 | 374.1K | 18,135,469 | I | ↗ |
| 2025-07-07 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 5,000 | 60.00 | 300.0K | 145,000 | I | ↗ |
| 2025-07-01 | Doudna Jennifer A | Director | S-Sale | D | Class A Comnmon Stock | 625 | 62.52 | 39.1K | 26,554 | D | ↗ |
| 2025-06-18 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 11,751 | 68.70 | 807.3K | 9,343,732 | I | ↗ |
| 2025-06-17 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 17,551 | 69.40 | 1.22M | 9,389,732 | I | ↗ |
| 2025-06-16 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 1,423 | 72.13 | 102.6K | 137,454 | D | ↗ |
| 2025-06-16 | Phelps Erik | Officer | S-Sale | D | Class A Common Stock | 1,900 | 74.41 | 141.4K | 97,779 | D | ↗ |
| 2025-06-11 | Leonsis Theodore | Director | S-Sale | D | Class A Common Stock | 184,116 | 67.59 | 12.44M | 21,731 | I | ↗ |
| 2025-06-03 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 4,600 | 61.63 | 283.5K | 872,040 | D | ↗ |
| 2025-06-02 | Epstein David R | Director | S-Sale | D | Class A Comnmon Stock | 250 | 55.20 | 13.8K | 27,661 | D | ↗ |
| 2025-06-02 | Doudna Jennifer A | Director | S-Sale | D | Class A Comnmon Stock | 558 | 55.20 | 30.8K | 27,179 | D | ↗ |
| 2025-05-20 | West Nadja | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 32,068 | D | ↗ |
| 2025-05-20 | Rogers James William | Officer | S-Sale | D | Class A Common Stock | 500 | 65.90 | 33.0K | 146,001 | D | ↗ |
| 2025-05-20 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 5,734 | 64.00 | 367.0K | 139,367 | D | ↗ |
| 2025-05-20 | Phelps Erik | Officer | S-Sale | D | Class A Common Stock | 8,403 | 63.21 | 531.2K | 149,108 | D | ↗ |
| 2025-05-20 | Leonsis Theodore | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 15,511 | D | ↗ |
| 2025-05-20 | LEFKOFSKY ERIC P | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 16,729 | 63.21 | 1.06M | 4,878,860 | D | ↗ |
| 2025-05-20 | Gottlieb Scott | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 34,836 | D | ↗ |
| 2025-05-20 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 11 | 63.70 | 700.70 | 876,640 | D | ↗ |
| 2025-05-20 | Frederick Wayne A.I. | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 28,511 | D | ↗ |
| 2025-05-20 | Epstein David R | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 27,911 | D | ↗ |
| 2025-05-20 | Doudna Jennifer A | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 27,737 | D | ↗ |
| 2025-05-20 | Belcher Eric D | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 15,511 | D | ↗ |
| 2025-05-20 | Bartolucci Ryan M | Officer | S-Sale | D | Class A Common Stock | 4,248 | 63.21 | 268.5K | 49,624 | D | ↗ |
| 2025-05-20 | BARRIS PETER J | Director | A-Award | A | Class A Comnmon Stock | 1,997 | 0.00 | — | 115,511 | D | ↗ |
| 2025-05-09 | Leonsis Theodore | Director | S-Sale | D | Class A Common Stock | 770 | 66.26 | 51.0K | 43,550 | I | ↗ |
| 2025-05-06 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 7,220 | 51.86 | 374.4K | 897,240 | D | ↗ |
| 2025-05-01 | Epstein David R | Director | S-Sale | D | Class A Common Stock | 370 | 53.50 | 19.8K | 25,914 | D | ↗ |
| 2025-04-29 | Bartolucci Ryan M | Officer | A-Award | A | Class A Common Stock | 5,000 | 0.00 | — | 53,872 | D | ↗ |
| 2025-04-01 | Gottlieb Scott | Director | S-Sale | D | Class A Common Stock | 4,000 | 48.13 | 192.5K | 35,397 | D | ↗ |
| 2025-04-01 | Fukushima Ryan | Officer | S-Sale | D | Class A Common Stock | 3,300 | 46.02 | 151.9K | 921,160 | D | ↗ |
| 2025-04-01 | Doudna Jennifer A | Director | S-Sale | D | Class A Common Stock | 625 | 48.12 | 30.1K | 25,740 | D | ↗ |
| 2025-03-31 | Frederick Wayne A.I. | Director | S-Sale | D | Class A Common Stock | 3,000 | 45.54 | 136.6K | 26,514 | D | ↗ |
| 2025-03-21 | Polovin Andrew | Officer | S-Sale | D | Class A Common Stock | 3,076 | 50.00 | 153.8K | 151,095 | D | ↗ |
| 2025-02-24 | Rogers James William | Officer | A-Award | A | Class A Common Stock | 4,372 | 0.00 | — | 169,122 | D | ↗ |
| 2025-02-24 | Polovin Andrew | Officer | A-Award | A | Class A Common Stock | 5,334 | 0.00 | — | 156,429 | D | ↗ |
| 2025-02-24 | Phelps Erik | Officer | A-Award | A | Class A Common Stock | 5,334 | 0.00 | — | 157,511 | D | ↗ |
| 2025-02-24 | Bartolucci Ryan M | Officer | A-Award | A | Class A Common Stock | 4,372 | 0.00 | — | 48,872 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-59.6K
Shares Outstanding
174.36M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Eric Lefkofsky Chief Executive Officer, Founder and Chairman | 783.3K | — | 39.99M | — | 720.0K | — | 41.50M | 96.38% | ↗ |
| 2 | 2025 | Ryan Fukushima Chief Executive Officer, Data | 422.7K | 55.7K | 10.65M | — | 450.0K | 19.8K | 11.60M | 91.83% | ↗ |
| 3 | 2025 | Andrew Polovin Executive Vice President, Chief Legal Officer and Secretary | 610.0K | — | 5.70M | — | 274.5K | — | 6.58M | 86.56% | ↗ |
| 4 | 2025 | James Rogers Chief Financial Officer | 500.0K | — | 5.63M | — | 225.0K | — | 6.36M | 88.59% | ↗ |
| 5 | 2025 | Erik Phelps Executive Vice President, Chief Administrative and Legal Officer and Assistant Secretary | 610.0K | 48.1K | 3.57M | — | 274.5K | 50.6K | 4.55M | 78.41% | ↗ |
| 6 | 2024 | Eric Lefkofsky Chief Executive Officer, Founder and Chairman | — | 800.0K | 27.75M | — | — | 5.0K | 28.56M | 97.18% | ↗ |
| 7 | 2024 | Ryan Fukushima Chief Operating Officer | 375.0K | 250.0K | 3.93M | — | — | 74.3K | 4.63M | 84.89% | ↗ |
| 8 | 2024 | Ryan Fukushima Chief Executive Officer, Data | 375.0K | 250.0K | 3.93M | — | — | 74.3K | 4.63M | 84.89% | ↗ |
| 9 | 2024 | Andrew Polovin Executive Vice President, General Counsel and Secretary | 591.7K | — | 2.13M | — | — | 2.5K | 2.73M | 78.22% | ↗ |
| 10 | 2024 | Andrew Polovin Executive Vice President, Chief Legal Officer and Secretary | 591.7K | — | 2.13M | — | — | 2.5K | 2.73M | 78.22% | ↗ |
| 11 | 2024 | James Rogers Chief Financial Officer | 500.0K | 50.0K | 2.13M | — | — | — | 2.68M | 79.51% | ↗ |
| 12 | 2023 | Ryan Fukushima Chief Operating Officer | 390.6K | 225.0K | 4.60M | — | — | 76.4K | 5.30M | 86.93% | ↗ |
| 13 | 2023 | James Rogers Chief Financial Officer | 491.7K | 50.0K | 2.76M | — | — | 2.1K | 3.31M | 83.55% | ↗ |
| 14 | 2023 | Eric Lefkofsky Chief Executive Officer, Founder and Chairman | — | — | — | — | — | 2.1K | 2.1K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eric Lefkofsky | Co-Founder, Chief Executive Officer, President & Chairman | 2M | male |
| Erik Phelps | EVP of Administration & Operations | 983.3K | male |
| Ryan Fukushima | Chief Executive Officer of Data & Apps | 948.3K | male |
| Andrew Polovin | Executive Vice President, General Counsel & Secretary | 884.5K | male |
| James Rogers | Chief Financial Officer | 725.0K | male |
| Kate A. Sasser | Chief Scientific Officer | — | — |
| Lauren R. Silvis | Senior Vice President of External Affairs | — | female |
| Melisa Tucker | Chief Data Officer | — | female |
| Mike Yasiejko | Executive Vice President & GM of Genomics | — | male |
| Patty Spiller | Chief Marketing Officer | — | female |
| Robyn Eckerling | Chief Privacy Officer | — | female |
| Ryan Bartolucci | Chief Accounting Officer | — | male |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TEM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
